Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alpha-1 Proteinase Inhibitor”

175 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 175 results

Testing effectiveness (Phase 2)Study completedNCT02614872
What this trial is testing

Study to Evaluate the Safety and Efficacy of Intravenous Glassia® Treatment in Lung Transplantation

Who this might be right for
Transplantation, Lung Rejection
Kamada, Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT04495101
What this trial is testing

Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19

Who this might be right for
COVID-19
Instituto Grifols, S.A. 100
Not applicableStudy completedNCT02922751
What this trial is testing

FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)

Who this might be right for
Biliary AtresiaAlagille SyndromeAlpha1 Anti-Trypsin Deficiency+3 more
Arbor Research Collaborative for Health 552
Testing effectiveness (Phase 2)Study completedNCT00499837
What this trial is testing

Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients

Who this might be right for
Cystic Fibrosis
Kamada, Ltd. 21
Not applicableEnrolling By InvitationNCT06892236
What this trial is testing

Preparation of IPSC for Cell Gene Editing for the Treatment of AATD

Who this might be right for
Alpha1-antitrypsin Deficiency
Fondazione IRCCS Policlinico San Matteo di Pavia 3
Large-scale testing (Phase 3)Study completedNCT02525861
What this trial is testing

GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study

Who this might be right for
Alpha1-antitrypsin Deficiency
Baxalta now part of Shire 34
Not applicableEnded earlyNCT02502201
What this trial is testing

Environment Effect on Six-Minute Walk Test Performance

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAlpha-1 Antitrypsin Deficiency
University of Florida 27
Testing effectiveness (Phase 2)Study completedNCT00067756
What this trial is testing

4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?

Who this might be right for
Alpha 1-Antitrypsin Deficiency
University of Florida 12
Testing effectiveness (Phase 2)Study completedNCT02001688
What this trial is testing

Phase II, Safety and Efficacy Study of Kamada-alpha-1-antitrypsin (AAT) for Inhalation"

Who this might be right for
Alpha-1 Antitrypsin Deficiency
Kamada, Ltd. 36
Early research (Phase 1)Ended earlyNCT01183468
What this trial is testing

A Research Trial of Aralast in New Onset Diabetes (RETAIN)

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Allergy and Infectious Diseases (NIAID) 17
Early research (Phase 1)UnknownNCT05315921
What this trial is testing

Study of OsrhAAT or Placebo in Healthy Volunteers

Who this might be right for
Emphysema Secondary to Congenital AATD
Healthgen Biotechnology Corp. 48
Not applicableStudy completedNCT01676688
What this trial is testing

Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Laboratoire français de Fractionnement et de Biotechnologies 17
Not applicableTemporarily pausedNCT00571272
What this trial is testing

Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC)

Who this might be right for
Liver DiseasesAlagille SyndromeAlpha 1-Antitrypsin Deficiency
Arbor Research Collaborative for Health 1,675
Testing effectiveness (Phase 2)WithdrawnNCT03385395
What this trial is testing

Study Comparing Weekly Intravenous Administration of OctaAlpha1 With a Marketed Preparation Glassia® in Subjects With Alpha-1-antitrypsin Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Octapharma
Not applicableStudy completedNCT00532805
What this trial is testing

The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency

Who this might be right for
Alpha-1 Antitrypsin Deficiency
Medical University of South Carolina 49
Large-scale testing (Phase 3)Ended earlyNCT01731691
What this trial is testing

Safety and Efficacy of (α1Proteinase Inhibitor, α1PI) in HIV Disease

Who this might be right for
HIV Disease
Institute for Human Genetics and Biochemistry 12
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Testing effectiveness (Phase 2)WithdrawnNCT02900183
What this trial is testing

Safety, Tolerability and Effect of ARC-AAT Injection on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels

Who this might be right for
Alpha-1 Antitrypsin Deficiency
Arrowhead Pharmaceuticals
Not applicableStudy completedNCT03383939
What this trial is testing

Inhaled A1AT in Adult Stable Bronchiectasis

Who this might be right for
Bronchiectasis Adult
Hospital Universitari Vall d'Hebron Research Institute 20
Large-scale testing (Phase 3)Ended earlyNCT04204252
What this trial is testing

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Kamada, Ltd. 98
Next Page